240 related articles for article (PubMed ID: 23497717)
1. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.
Chen DY; Lin CC; Chen YM; Lan JL; Hung WT; Chen HH; Lai KL; Hsieh CW
Arthritis Res Ther; 2013 Mar; 15(2):R39. PubMed ID: 23497717
[TBL] [Abstract][Full Text] [Related]
2. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
[TBL] [Abstract][Full Text] [Related]
4. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
Chen DY; Hsieh TY; Hsieh CW; Lin FJ; Lan JL
Arthritis Rheum; 2007 Dec; 57(8):1530-8. PubMed ID: 18050226
[TBL] [Abstract][Full Text] [Related]
5. The implication of interferon-γ-producing immunocompetent cells for evaluating disease activity and severity in adult-onset Still's disease.
Ichikawa T; Shimojima Y; Kishida D; Ueno KI; Sekijima Y
Int J Rheum Dis; 2021 Sep; 24(9):1176-1185. PubMed ID: 34241971
[TBL] [Abstract][Full Text] [Related]
6. Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease.
Liu Y; Xia C; Chen J; Fan C; He J
Rheumatology (Oxford); 2021 Jan; 60(1):297-303. PubMed ID: 32757000
[TBL] [Abstract][Full Text] [Related]
7. Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adult‑onset Still's disease.
Chen DY; Chen YM; Chen HH; Hsieh CW; Gung NR; Hung WT; Tzang BS; Hsu TC
Mol Med Rep; 2018 Feb; 17(2):3364-3371. PubMed ID: 29257322
[TBL] [Abstract][Full Text] [Related]
8. Germinal center kinase-like kinase (GLK/MAP4K3) expression is increased in adult-onset Still's disease and may act as an activity marker.
Chen DY; Chuang HC; Lan JL; Chen YM; Hung WT; Lai KL; Tan TH
BMC Med; 2012 Aug; 10():84. PubMed ID: 22867055
[TBL] [Abstract][Full Text] [Related]
9. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.
Shimojima Y; Kishida D; Ueno KI; Ushiyama S; Ichikawa T; Sekijima Y
J Rheumatol; 2019 Oct; 46(10):1268-1276. PubMed ID: 30770498
[TBL] [Abstract][Full Text] [Related]
11. Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
Shimojima Y; Ichikawa T; Kishida D; Takamatsu R; Sekijima Y
Clin Exp Immunol; 2021 Nov; 206(2):184-195. PubMed ID: 34319596
[TBL] [Abstract][Full Text] [Related]
12. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Interleukin 33 and Soluble ST2 Are Associated with the Extent of Disease Activity and Cutaneous Manifestations in Patients with Active Adult-onset Still's Disease.
Han JH; Suh CH; Jung JY; Ahn MH; Kwon JE; Yim H; Kim HA
J Rheumatol; 2017 Jun; 44(6):740-747. PubMed ID: 28365573
[TBL] [Abstract][Full Text] [Related]
14. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
16. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
18. Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.
Kim HA; Choi B; Suh CH; Han MH; Jung JY; Sayeed HM; Kim YW; Sohn S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106835
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of TLR2 and its correlation with disease activity and clinical manifestations in adult-onset Still's disease.
Han JH; Ahn MH; Jung JY; Kim JW; Suh CH; Kwon JE; Yim H; Kim HA
Sci Rep; 2022 Jun; 12(1):10240. PubMed ID: 35715478
[TBL] [Abstract][Full Text] [Related]
20. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease.
Hsieh CW; Chen YM; Lin CC; Tang KT; Chen HH; Hung WT; Lai KL; Chen DY
J Rheumatol; 2017 Aug; 44(8):1142-1150. PubMed ID: 28507179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
